about
SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOSAngiotensin receptor blockers and risk of prostate cancer among United States veteransCritical Roles of Reactive Oxygen Species in Age-Related Impairment in Ischemia-Induced Neovascularization by Regulating Stem and Progenitor Cell FunctionMitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular DysfunctionThe effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient miceRole of the immune system in hypertension: modulation by dietary antioxidants.PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosisLeukocyte-dependent responses of the microvasculature to chronic angiotensin II exposureMolecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.Candesartan reduces the innate immune response to lipopolysaccharide in human monocytesOver-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cellsEffects of over-expression of TLR2 in transgenic goats on pathogen clearance and role of up-regulation of lysozyme secretion and infiltration of inflammatory cells.Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular functionTailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-αInhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertensionRole of T lymphocytes in angiotensin II-mediated microvascular thrombosisMechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studiesInflammation and sleep in healthy individuals.Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques.Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient miceHypercholesterolemia blunts the oxidative stress elicited by hypertension in venules through angiotensin II type-2 receptors.Effects of salt-loading hypertension on nociception in rats.Angiotensin II induces cell growth and IL-6 mRNA expression through the JAK2-STAT3 pathway in rat cerebellar astrocytes.Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor.Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen.Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery.Effects of dexamethasone on angiotensin II-induced changes of monolayer permeability and F-actin distribution in glomerular endothelial cells.Effects of valsartan on inflammatory and oxidative stress markers in hypertensive, hyperglycemic patients: an open-label, prospective study.Renin-angiotensin system blockers and modulation of radiation-induced brain injury.ACE2, a promising therapeutic target for pulmonary hypertension.Roles of proteolysis in regulation of GPCR function.Targeting vascular (endothelial) dysfunction.Therapeutic targets of renin-angiotensin system in ocular disorders.MAS-mediated antioxidant effects restore the functionality of angiotensin converting enzyme 2-angiotensin-(1-7)-MAS axis in diabetic rat carotid.Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats.Many Faces of Renin-angiotensin System - Focus on Eye.Angiotensin II Differentially Induces Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Production and Disturbs MMP/TIMP Balance
P2860
Q24605300-47052D07-9F2C-4119-A148-B8487C591771Q24626548-D38CC165-F156-4DC7-BC08-60F8DE5DA1A8Q26772290-8532AB2D-5110-48AA-A60F-86ED4CB4F9D7Q26799985-1EFC5024-07B4-4E42-B6C3-377389A9FE79Q28535046-20A5ED96-744E-4BA7-9F5E-16B54BD26818Q30424339-54059CF0-67C4-42FB-BF2A-126417528438Q30482025-B264FB0B-5B49-4A54-93B0-B1DCF0EAE0D7Q30528414-FE2522B0-2303-4049-B9A8-D2A2A389736FQ33349894-71070AB0-5966-4BDC-BF08-186230BAC4FCQ33793455-05BB5706-F3DB-4714-B2C6-B9B800DFEE64Q33799413-B6682B72-ABFC-41FC-8C05-4B0722F9D8F3Q34087095-79AD3A4F-8C43-4AB7-966E-C0CCE1FBFBE0Q34280097-10068805-35CD-4770-81B4-4D3B7CD0A2C7Q34452601-559CDB8F-00BF-4C8F-8E30-AF95A81B2645Q34538722-18D745A9-32F5-4BB5-81FE-1EBE270E8FC9Q34977437-74668B2F-4B04-4DCB-AEB6-7C2AC515E2CFQ35013600-F57DFA21-208A-4764-A51B-F6268C3F0E41Q35016422-12F0010F-74AA-4E89-8E14-66B97641F31BQ35421048-3C10014D-392F-4E21-BB85-E8B8DF900A5DQ35786784-DA8265C9-2E3E-4187-B31C-120929EC729FQ35995458-A7DED30C-831B-412B-B5CC-E8F91690277EQ36262694-1E98255E-1142-4436-AF21-F776C493317DQ36377589-0B5C2AC5-6318-4114-8661-D5B044321A79Q36703439-651A6D0E-7E10-49E0-9514-DCFF50886176Q36884854-730A74DF-E6D3-440D-BCDF-21F936E1F657Q36895475-B0E9E6DA-030E-4564-8F99-B3FAA9505429Q36977043-F4550FAF-D67B-4232-A88E-F9EE04DD7FF7Q37210914-EF70A33C-04BE-449D-AB84-F87341503D8EQ37281652-7510BD5E-ADE4-43E9-ABE6-C38A64A56B9CQ37289130-A02045E2-9423-4381-941C-D5B7BCEC53F7Q37672751-5D000D45-BAE0-400D-9015-0B709E6BB5B3Q37768187-35E32F10-2EC8-4CF8-B8E8-A2F84025909DQ37826865-B2A94DE8-B6CE-44B5-ADBF-797497BCDDF1Q38050189-18245487-C36E-47EB-B4BE-02F5E9DEDDD9Q38836199-E56B7C4E-C21F-4E1B-9C40-84ADDE374FAEQ39214578-1769EFB1-C89E-4E45-912B-FF5E4D3B80CAQ39644152-9A71CD7F-4E63-4F20-856C-13E5452A8F3CQ40673218-CD6FA8EC-A423-437F-BAEC-50BE89B10339Q41015495-7239D76C-CDA6-4655-92A3-756BA368519BQ41814560-06A74C98-D3ED-41A6-807F-1EF031DC495E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Angiotensin II and vascular inflammation.
@ast
Angiotensin II and vascular inflammation.
@en
type
label
Angiotensin II and vascular inflammation.
@ast
Angiotensin II and vascular inflammation.
@en
prefLabel
Angiotensin II and vascular inflammation.
@ast
Angiotensin II and vascular inflammation.
@en
P2093
P1476
Angiotensin II and vascular inflammation
@en
P2093
Eero Mervaala
Heikki Vapaatalo
Zhong Jian Cheng
P304
P577
2005-05-25T00:00:00Z